0000950103-07-000823.txt : 20070403 0000950103-07-000823.hdr.sgml : 20070403 20070403113944 ACCESSION NUMBER: 0000950103-07-000823 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20070402 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070403 DATE AS OF CHANGE: 20070403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Shire plc CENTRAL INDEX KEY: 0000936402 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29630 FILM NUMBER: 07742360 BUSINESS ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: - BUSINESS PHONE: 1264333455 MAIL ADDRESS: STREET 1: HAMPSHIRE INTL BUSINESS PARK STREET 2: CHINEHAM BASINGSTOKE CITY: HAMPSHIRE ENGLAND RG STATE: X0 ZIP: - FORMER COMPANY: FORMER CONFORMED NAME: SHIRE PHARMACEUTICALS GROUP PLC DATE OF NAME CHANGE: 19980302 8-K 1 dp05227e_8k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 2, 2007

Shire plc

(Exact name of registrant as specified in its charter)

England and Wales

(State or other jurisdiction of incorporation)

0-29630	98-0484822
(Commission File Number)	(IRS Employer Identification No.)

Hampshire International Business Park, Chineham, Basingstoke,

Hampshire RG24 8EP England

(Address of principal executive offices) (Zip code)

Registrant's telephone number, including area code 44 1256 894 000

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.f13e-4(c))

Item 8.01. Other Events

Shire plc has issued the press releases attached as Exhibit 99.01, Exhibit 99.02, Exhibit 99.03, Exhibit 99.04 and Exhibit 99.05 which are incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits. The following exhibits are filed herewith:

99.01	Press Release dated April 2, 2007
99.02	Press Release dated April 2, 2007
99.03	Press Release dated April 2, 2007
99.04	Press Release dated April 3, 2007
99.05	Press Release dated April 3, 2007

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	SHIRE PLC


	By:	/s/ A C Russell
		Name: Angus Russell
		Title: Chief Financial Officer

Dated: April 3, 2007

EXHIBIT INDEX

Number		Description
99.01 99.02 99.03 99.04 99.05		Press Release dated April 2, 2007 Press Release dated April 2, 2007 Press Release dated April 2, 2007 Press Release dated April 3, 2007 Press Release dated April 3, 2007

EX-99.1 2 eex9901.htm

EXHIBIT 99.01

Hampshire International Business Park Chineham Basingstoke Hampshire RG24 8EP United Kingdom Tel +44 (0)1256 894000 Fax +44 (0)1256 894708 www.shire.com

Press Release

2 April 2007

Shire plc ("Shire")

Purchase of Shares by Employee Benefit Trust

Shire has today been notified by Towers Perrin Share Plan Services (Guernsey) Ltd (the “Trustee”) as trustee of Shire plc Employee Benefit Trust (the “Trust”) that it will commence an irrevocable, non-discretionary programme to purchase Ordinary Shares of Shire plc (“Shares”) and American Depositary Receipts of Shire plc (“ADR’s”) for the benefit of the Trust during the period commencing on 02 April 2007 and ending on 30 April 2007. Any purchases will be conducted within certain pre-set parameters agreed between the Trust and an independent third party broker.

For further information please contact:

Investor Relations		Cléa Rosenfeld (Rest of the World)		+44 1256 894 160
		Eric Rojas (North America)		+1 484 595 8252

Notes to editors

SHIRE PLC

Shire’s strategic goal is to become the leading specialty pharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire believes that a carefully selected portfolio of products with a strategically aligned and relatively small-scale sales force will deliver strong results.

Registered in England 2883758 Registered Office as above

Shire’s focused strategy is to develop and market products for specialty physicians. Shire’s in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe.

For further information on Shire, please visit the Company’s website: www.shire.com.

Registered in England 2883758 Registered Office as above

GRAPHIC 3 logo.jpg GRAPHIC begin 644 logo.jpg M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC M+B!6,2XP,0#_VP"$``("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(" M`@("`@,#`@(#`@("`P0#`P,#!`0$`@,$!`0$!`,$!`,!`@("`@("`@("`@," M`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$! M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,` M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I M*C0U-CH.$A8:' MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7 MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1 M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6& MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76 MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`#D`K`,!$0`"$0$#$0'_V@`, M`P$``A$#$0`_`/W\H`*`"@`H`AGN+>TB::YGAMH8P2TL\B0QH`,DL[D!1CWI MI.]HIW[)?H@V\K?(^;]?_;"_9L\-7=S8:C\6O"LEW:,\=Q!IMZ-4>&1"0\3C M3Q+B0$$;>N01U%>Y2X9SRK&,HY=5C&6W.N3Y^];3_-=SFGB\-3WJQ6K6CZK? M;MU,F3]MO]E^*UENC\6?#^V%=QMXSL#_SQL4A,TO?[B&M(\*Y]S**RZHO M-V4?G*_*OO%]/A5\1O#&I^+_#'BVP;1-"N8++7IM3$ MNBSZ%>71B%M;:Q::FD$VG2RM/$(Q,B;RXVYS7D8O)LRP->EA:^%E&M73=-0M M-5$M^24+J5NO*W;J:TZU*I%RA)"))RTDTDKJJJH))8`"I((/B#3`00<$$?:.N:]!91F?3+Z]O^O4^OR(52FTFIQL]M4=OINI:?JUC; M:EI5[;:AIUW&)K2]LIH[BUN(B2!)!-$Q21,@C*DC@UQ3ISHSE3J0=.<'9QDK M.+[-/8M-6TV+M0`4`%`!0`4`%`!0`4`%`!0!B>)?$.E^$?#NN^*-7$D;SW-_.+*V:5O+\L$O)^U9;D^4\-X:-6JX M>WM"-3$35W*;;M&C%IN-WI&,%[2?6^R^=JU\1C)NG235.^R6B7=NVBMO?S[V M,'PO^RAX[U[2O[1\'^%M;^+$QMIHC<^#A%8^`M-U6*4PRV3>-M5,%OXINK1U M(G@T-)K4D@)J>X,HZ:^>X'#5'3Q>(IX!IWY:S;KN&C4G0A>5)36WM6JBOK25 MKD4\&Y*7(G5>OO134+M_S67-:VO+>_,K.R;/)/B/\"_C!\+XEU'Q]\-_$7A/ M3)9TM8M0N--G_L3[1(KO':1:K&TUL\Y5)"$-PSD*3R!7;A,UR['/EP>,I5Y1 M7PPE'G275PTE;7=HYZN'KT=9TG!;7M:/EJM-OF^NMSTS]FC]J_X@?L]>);`0 M:C?:W\/;F[@7Q%X,O+AY[7["7*SW>@B9C_9.J1)))*@A,<4[J%G5LAX^#/,@ MPF<8>490C1QD8OV59*TD]TIVMS0>SO=Q3O&VQMA<95P\HJ]Z2T<6[*W==FKW M\]GTM^K?[7GASPA=_LY?'CXO^#%TY]'^*/@'X(3)?Z6BP6VOG3?B2FHVVMW5 MLL2;[R32]?TN(3R`2E(!'(,P@#X'AO$8JGG64Y7B>95,NKX_W9.[I\^$<7"+ MN_=4JMC5'ZK7JT](U(4K-:7M4O>WI):]3\5_P!GI%'Q[^">%48^ M+'P\Q\H&,>+=)]J_2LZ;_L?-M7_N>*_&A,\3#-_6,.KNWM(=?[R/ZQZ_GT^M M"@""Z4M;7"J"S-!*JJ!DDF-@``.I)JH_%'U7Y@?RM7/[+_[0[7-PR?`SXHE& MGF92/`GB(`@R,01_Q+NA'/O7[_\`V[E'_0WPG_A32Z_]OGR7U;%1]WV%16Z* M,K?@K']$?[)?A_6_"G[./PD\/>(](U'0-] MSZ;#)QH4DXN#4=4U9KY.UCZ)KPS<*`"@`H`*`"@`H`*`"@#S/XK_`!>\`?!3 MPG=>,?B%KMOHFEP^9%9P',VI:SJ"PR31:5HUA'^\O;^41G``6.,9DGDBA1Y$ M[\NRS&9IB(X7!474GHY/:%.+=G*:<15 MVZJ_,GXH?'_4/%6D2>`/AUX>T[X4_"2TEV:?X/\.;H]4UN"*+RH;K MX@>)O^/SQAJ+R--.1=LUO&TX"Q.T"2G[C`Y5##U(XK&UI8_,-.:M4^&GWCAZ M2:A0A:R]VTY6;CLUS:[W[?T;_`CXA? M"_QW\._"_P#PJ[7-#OM(T?P]HEB^BZ7QIZ?\`E8\!937WYH1\M=/+9_F_5GVK\9_A M_P"*?A7_`,$V]=^'OC.ZTV\\1^%-$\.:;>SZ/UHV5$O`>O:IX2^$_A MB#X@WVERFTN?%=_JNQ039B:=9;&%V1FMY9XBLK?G MF4\#5\31AB,RKRP49J\:,(*55)[.;;4:;>_+:A[6(S.G1;A2CSN+U? MV5HGI;?>VZL[O72_@'A/_@JU\1+34(_^$W^&/@[6-*)<2)X8O]8\.:C"&"A' MCDU.?689]AW$QF.+?D`.G6O8Q'`&`<7]5QM:A/2WM(PJQ\[J/LFK]+/3?4YH MYO.ZYJ*M?HVG9W_%:>MGM?3]8/@E\=O`WQY\!1>._`]Q/Y,1>UUK0[\10ZSX M=U:*%9Y=*U2*&22,2^4\38SZIB4O>UIU(W]G M5@W;GA=)VO=232<6FFCUZ%:%:G&I#1=5UB^J_P"&T/SJE_X*R:1%+)$?@=J) M,?"'X,?%>3X9WFJ1?%^TUJ[@T-/%<-E)H`T9K-6274&\/ MS#43*;L8*V]OMV'AL\>3A.$98G,LTRY8]4_[,=-.?L6_:>T3?P^U7+:W\TKG M76QJHT:55T]*G12M;KV_RMYE#]G_`/X*"^'?C;XWU+PI?^`6^'^FZ/X.\0^, M]2\3:IXQMM0L;+3O#IL&O3V]AJ*0M)$+C3O#5B+:[%I*P26. M6[OK:4H<26L;'Y?4R[@&\(SS/%RI2:3]C04;QO9VE5ES1O:Z:C!I/:3.>MFL M8MQH0O9_%+1.W9)I_/\`#4^]_@C\<8?&_P"SOX8^.'Q%GT#PA!>Z3K.I^(KF M.::TT'2X=(\0:MHWG+)?W$LD<4Q4W5IH-E!+>W-E)C,9N+ MK3I2N"\*$[1]5E_`%62A/,L8J":3=*A'FG&_1U)6@I='RQG&^TFEKY]7-80D MHT8`]6TSS29;;1+G7_#]^(2. M%BO;V^U:(2*>G6X`R[DM0QF(HSMO/V=2-[K7E4:;U5_M=O.^$, MWJ*_/1COIRMQT?36_P!_7MU/TK_9S_:\^%W[1L,]AX?DN_#?C2PADN;_`,$Z M]);#4C:1&(2ZEH]S;N8M9TM7GC1Y(Q%-$Q'GV\2O&TGP^=<-X_(^6=2U?"2: M4:]--14G>T*D7K3F[-I.\9?9DVFEZF'Q=&NDH/EG_*]&OT>S\[*]K'U37SYU M!0!\T_M,_M+>%?V66 M`2R*&DD:6.&%2\A:/WLM>6.S=M_2U]3P7X)_LS^-?B!XHL_CW^UA?#Q5XTD2"^\%?#N8H_A7P M'9SJTT4=SHQC-L=2BW0%+=-\<4B--.]U=E98/8S7/L-@L/+)^'8?5L-&\:^( M2:JUI)_9GI+E>MY.TFGRQ4(74L*&'J3E&OB[2FM80Z03UU5OB6B\K;MZGW9X MN\*:-XV\*>(?!FOVPN=#\3:+J.A:G;@(K&RU.UEM)C"65A%.B2[XY`I*2(CC ME17R.&Q%7!XBABJ$N6KAYQJ0?]Z+4E?;1VLUU3:.Z45*,H->[)-->OD?S0_M M$?LE_$_]GG5;^75].EUSP&MWY>C^.].C7^SKF"8YMH]4MDD:71]1"D)(DJ^2 M74^3+(IX_<5V2G'JFM;-72=SYC$X*IAI;CEC*4&G%N+6UCZL\!?MU_M,_#^UATZU M^(-QXDTV!@R6?C*RL_$DI`&!$=6U")M3$/HBWJ@?PXKP<7PMD>,DYSP,:,WU MHN5%>O)!JG?_`+<.RGF&*IV7/S+LTG^.^VG;K:^I^A7P(_X*;^'?$]]IGAKX MT:!;>#M1O9EM1XPT)KB3PP)G7$3ZEIMP\UWI432`*9HY[M%,JEECC5G7X[-> M!*M"%2ME5:5>--7]A4LJMNJA.*C&3[1<8MI:-NR?HX?,X2:A5C[-WLFMM6DK M]M]7MI>VME]-?MZNC_LC_%MXV5T>U\&NCH0R,C?$'PD5964X92"""."#7A<( M)KB/+TU9KZPFGHTUAJQT9@T\%5:=T^2S7^.)_-+:&[6ZMOL!G6]\^(6GV9F2 MX^TEU$`@92"LQD*[2"#DCFOVZR?NNUGH[[?/R/F8I\RBM'>R^?H?NK\,?^"8 M?PJLO"6E2?$[5/$NN>,;JTBN=772=272=(TVYG7S386$$,#33"W#")YYYG\U MXVD5(E<1K^58[CK'/$3C@*5*EAHNT.>+E.2_FE[R2N[M))63LVWJ?04LJHQA M%5;RGULVEKV2[?CKY6_.7]LW]F:R_9J\?:+IV@:K>:KX0\8Z9=ZKX>;4_+.I MV$FF7$%MJNF7D\"1QW?DR7=G+'.L<1,=XJ,I:)I)/L^&<[EG6#JU*M.-+$86 M<85%&ZB^=.4)Q3UCS)23C=ZQ;NDTEYN.P?U2:<'^[EMW3ZI]^Z?R]?;_`/@E M_P"-=2TGXN>-_`JS/_8OBSX?:AK$]J3^[&L>%[ZQ6PN5&/E<6&M:M&2,;A(N M<[5QYG'.%ISRS#8NUJN%Q,(1>WN5HRYH]OBIP?R\V;Y3.4:E2%_<:V_O=+?) M2OWT/S5O/^/NZ_Z^9_\`T:U?:GDGZ!?M* M*>GOX;_TB9[&._W+"]-?_;6?!>D7.KQR76EZ+)=+/XCMHM`N+6S+";4K:YU+ M3KV/3<)\TB3:CI]@3&.',2J002#]5-4TE.:2C1;FG*UH-1E'GUT3492UZ)NQ MY5.4XWA3_P"7GNV76[T^=]NJ/U"^'W_!+#QQKNA6&K>._B'IO@O4;VT@N7\. MV.@OKUWIKSJ)/LU_?_VO:0?:HU8+(D"2HKA@LSJ`Q^%Q?'N"P]6=+"X.>)A" M32J>T5*,K:7C%TY2L]TW9V^RCU*>4S=-.4_9S=G:VU^CVU7D['@?[4WC76?` M>A^%OV0-(UZ34O"OP4DOT\1:S;P2:4GC#Q1K6I7WB1>];J<1:?I%KKD=FD M+S2AKN.YG/W81%Z^186CB:E;B.=%4\3FBBZ<&U/ZO1A&-*RERQ]^JZ;G*22] MQQBK7G?'&572A#!QEI05I/1*3WVN[6V[WOT9WG[$O[%FF?'ZQU3X@_$*^U"R M\`Z9J,NB:9IFD7"6FHZ_K%K':W%Z\]VT3M::1;PW4<9\D+---(P62);=O.Y. M)^)I9,Z>$P<(RQE6/.Y33Y*=-MJ+237-.33M?W8I:I\RM6`P,:Z=6H[4T[** M=F[+7;5:M?CW3/N3XA?\$RO@=JGA;58?A[_PD'A/Q9'8N^BWMQKVH:SIDNH0 M1$P0:I9ZI+.?LD[C;(UN\#J7W@G;L;Y3!\^HTXTY*+>KB MX):QOHFFK*VE[GH5LLH.#5)>RFOA?2][NZ[/;RZ=C\.O#VO>,/A%X^L]9TN: M\\.>,_`OB%@R+(T4UGJFCWC6]_IMWY+@36[R0SVMQ"2TFR MOOVZ^2N9WQE^+/AGX)?#S7_B%XID!LM'@"V>G)-'!=ZUJUQE-/T>P+AO])N) M1U"/Y<:2RLI2)JO+,NKYIC*6#PZUF_>E:ZIPNN:G*I M+11V6S;Z)>;/SJ_9`^&GB3]HOQ[J7[77QM9=45=5N+/X8Z!*)!IFGOIDDEM) MJ%M8O^Z_LS3W8VUFIW%KNWNKJ3,T<RO"^)FOB:G9\K MEOSU+,K+5W4(O9+HTNEM?7?U_6:OSL]4X#Q[\4_ MA[\+K?3KKQ_XKTOPK;ZM//;:;+J;S(MY/;1I+<1P^3"YW)'(C'('#"NS!Y?C M<>AP6F?M#?L]^/-1LO!^G?$'P MEXCO]?G73K/0V$T_]HSSA@MLL-S9B-V<`@!B,].]=D\FSG!0EB98.KAX4%S2 MG=+D2ZW4KHA5J$FH*I%MZ)777R.!^(O[#?[.'Q&E:\O/`EKX;U)@V=0$RR> M'7=V))EN+73VCMKJ7<2=TT+GD^M=F"XKSK`I0CBG6IK[-9*>BTLG+WHKT:Z& M53`X:;NZ=GY-Q\ME9'P]\4?^"5TL$5UJ'PB\>23M%`TD/A[QA;Q>9<3*CL8H M=:TZ.)8%9@JJ);24\\MWKZG`M2BW9*__`#[E=OY37H<%7*4M M:,^5+I+\=5Y>6_4_(S7]`UGPIK>J^&_$.G7&D:YHE]<:;JFFW2A+BRO;60QS MP2A6925<'#*S*P(925()_0Z56G5I4ZU&:G2J14H26SC)737JCQI1E3DX27+* M+LUV9^H/A'XIZUX__P"":_QI\.Z_<&[O/AKJ_@_PWIUW([/(J35K1]K'#UXS&1E)!!X()!KZO-IRIY5F>=AE_M%!=/:05O)R2?WG]9M?SX?7GXZ?\%:(H_LGP-GV+YJW'Q`B#XPPC M:/P@Y3/]W./_0]$KW^-/\`D1/_`+"\-^54PRK^++^NDSX-O/\`C[NO^OF? M_P!&M7U9Y9^@7[2G_)G?[$_;_B3^./\`T=H]?)Y/IQ+Q3Y3PW_I$SV,=I@L+ MZ_\`MK/,OV$/"NE>+?VH_AG9:S;I=66ESZWXD2VE4-&]_P"']`U/5-)=E/!\ MG58+.X`/&;<5V<55ZF%R',)4I.$Y1A3NM+1JU80G]$2C\SDR^$98JFI?9O) M>JU1_317X8?4'\H'[1MW/>?M`?&ZXN6+2GXL?$"/)SQ';^*M4MX%&>BK!%&H M'0!1CBOZ"R:*AE&5)*UL'AG;:S=&#:MWNW?S/DL4W]9KWTM4DODFTOP.Q^&/ MQ,_:E\+^$K72?A3J?Q+L_!T=W?S6D7AC2M4N=)^V3W+MJ#136EG)&TQNMXDP MQ(8$'!&*QQN!R.O7<\?1PLL1RQ3=64%/E2]W1R3M;;35%TJN*A!1I>T4([%-=,][J%],]Q>7<[ M"P&Z:6>1Y&/=G)[UZM/%9=0ITZ-+$X>G2HQ4(156FE&,4E&*][9))(YY4Z[D MY.G.[=_AEU^1_0-^P-'XALOV8?!&C^)=)U/1=0T/4?%FFQ6>K6%SIMY]B/B; M4[^WD:WNT23RS]N=$1HWAK MPVGC*[7:WX@N=0T^V>8`X*6FG:6X0D9!U*?UK[#@#`0A@\1CVOWF(K>P M5MXPIJ,FEYSE-7_P1.#-JCYZ=.UJ:UTTN^OW*UO.Y^R_PV\+Z9X)^'W@OPEH MT,,&F^'_``QHNEVJP*JQN+73X(Y+@[``TD\HDF=^KO*S')8U^98[$3Q6,Q6( MJ-\]:K4F[].:3=O1+1+HE8]FE%4Z=.$=%&*2MZ?J=M7*6?GO_P`%)_AMJ'C; MX`1Z_H]C->ZC\.O$UGXEN([=#).GA^XL[S2M;E6->3'!]JL;R4_PQ6$K?PU] MGP/C887-IT*DE"&-I.G&^B]K&49P7_;R4XI=92BCSLSI.6'YHJSI._\`VZU9 M[>=G\C\"O!'B[5_`'C#PQXWT!HH]9\)ZYIFOZ9YZ>9;M>:7=Q7<,=Q'QOMY& MBV2)_$CL.]?K6)P]+%8>OA:R?L:\)4YI:/EFG%V?1V=T^CU/GJ4W2J0J1WA) M.WH[V^9_1_\`"+]MKX%?$_P[9ZC=>+=-\&:_Y2KJOASQ)<"QN+.Z55$S6]RX M\FZLFD+>7*'5F7[R`U^+9CPKFV7UI0IX>6)HW]RI27-==+Q6L96W5K7ZGU%' M&4*D8VFHR_E>CO:[.T\7?M8?L_>"]'O-7U'XF>'+Q;2!YH['1[M=3U"\D524 MMK2"U#!IY"-JAW09/)%(;C4K*QD96EMK&.&"QLEG9`% M-RUI:0O*5`!D=R.#7[7EF$>7Y?@\$Y\[PU)0`=7\+?\$VOCWXJU6W-K'\0/$GA+4]$5QM>?0=(\9^ M"]+M[PCLDVHKJIC_`+T:(XX<5\MC,73J\;91A:;UP5*O&IY5*F'KS:^4/9W\ M[KH=\:3I977;7*ZC@_ESQMZ>GSZGQ%^SU_R7OX*?]E8^'G_J6Z37TF=?\B?- MO^P/%?\`IB9P8;_>/O\` MT1X2K](\/OCS+TI?G,\7./\`F'_[?_\`;3Y;_P"";'_)RA_[)IXX_P#0]$KZ M#C3_`)$3_P"PO#?E5,,J_BR_KI,^#;S_`(^[K_KYG_\`1K5]6>6?H%^TI_R9 MW^Q/_P!@?QQC_O\`:/7R>3_\E+Q3T?/AK?\`@$SV,=_N6%]?_;6.[^\L)H-`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`"OQ;`T#F,R1::]U; MR8SEX9;OP#_X)G^,-5U73=>^-US;^'_#D2K=2>%M-N1< M:WJ#AT:.TOIX_P!WI\!`<2J,R=-IY-?)9OQOA:,)T M3V:Z'H8?*Y74JSY(JSY5ONG9]M+W]3](?VJ?ACJ?B7]EWQQ\,/AEXWMPRK)DK';0R.0.?EK] M&S3B+)*^69A0HX^$JM;#5Z<(V:O.=*48KYMH\:A@L13K49.G)*$X-Z;)23?X M']$]?C!](?F?_P`%%_@A\3OC+9_">+X;^%[GQ&_A^Y\8OJRVTL47V)=1B\-K M9%_-89\TV=SC'_/(U]UP7F>`RV6/>-Q,<,JBI*'-?WK.=[6[:7]4>7F5"K5] MBJ4')1Y[VZ7Y;?>>`?L-?LQ?&[X5_',^*?'7@B]T#0?^$$\5Z4+^>:!X_M^H M-I1M(,1N3ND$$N#C^`U['%6>95C,H>'P>,C6K?6*$^2*:?+%5.9_*Z^\QR_# M5J%5N4'%=WITE_F?(5Q^P]^T_)<3R+\+]3VO-*Z_Z3:?=9V8?\M/0U]'_K/D M'_0QA]S.'ZAB?^?;^X^R?CG^S-\:_%/[,W[*_@?0?!-[>^)_`.F^+(/%>EI- M`LNE2:A+IAM%E9G"MY@@E(VD_=KYS+,[RJAGO$.*J8R-/#XJ5#V,VG::C&:E M9+LVCT<5AZL\+AZ<8-2@]4NFC1@_L3?LM_'/X8?M"^%?&'C?P+>Z%X=T_2O% M,%UJ,TUN\<,NH>'M0L[1"L;DYDN)HT&!U:M.)\]RG&Y+BL-A,9&K7G*ERP2: M>E6$I?@FS'`X2M0Q$9R@XQ2EJU;=,_<&ORD]T\'_`&A/V?O!G[1'@A_"7BE' MM+VRE>]\.>(+1$.H:%J3($::#<,26TR*J30-\LBJN>47'KY-G&)R7%*O0]ZG M+2I2;M&%A*G6%;W;75W:6 MS72_4\&IE^)I27+&ZULXO:VNO;]3S"+]G/\`:,UB:WL1\,_'UZ[2)'!%<6ER M\<9/R!@;B;9$H!QGC`->@\XRB"6XM%SF2 M/$A*BOB.(.,J\M?>[/34]+"9:Z4U4KV;CK&*V MOO=^A^P]?FQ[`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`! &0`4`?__9 ` end EX-99.2 4 eex9902.htm

EXHIBIT 99.02

Hampshire International Business Park Chineham Basingstoke Hampshire RG24 8EP United Kingdom Tel +44 (0)1256 894000 Fax +44 (0)1256 894708 www.shire.com

Press Release

2 April 2007

Total Voting Rights

In accordance with the Transparency Directive's transitional provision six, Shire plc notifies the market of the following:

At close of business on 30 March 2007, Shire plc's issued voting share capital consisted of 551,534,652 ordinary shares with a nominal value of 5 pence each and 1,285,489 special voting shares of 0.0001 pence each. Each ordinary share carries one voting right and each special voting share carries three voting rights. Shire plc does not hold any shares in Treasury.

Therefore the total number of voting rights in Shire plc is 555,391,119.

The above figure (555,391,119) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Shire plc under the FSA's Disclosure and Transparency Rules.

T May

Company Secretary

For further information please contact:

Investor Relations		Cléa Rosenfeld (Rest of the World)		+44 1256 894 160
		Eric Rojas (North America)		+1 484 595 8252

Notes to editors

SHIRE PLC

Registered in England 2883758 Registered Office as above

For further information on Shire, please visit the Company’s website: www.shire.com.

Registered in England 2883758 Registered Office as above

EX-99.3 5 eex9903.htm

EXHIBIT 99.03

Hampshire International Business Park Chineham Basingstoke Hampshire RG24 8EP United Kingdom Tel +44 (0)1256 894000 Fax +44 (0)1256 894708 www.shire.com

Press Release

2 April 2007

Shire plc (the “Company”)

Notification of the Exercise of an Option and Sale of Shares by a Non-Executive Director.

The Company was notified by The Honourable James A. Grant, P.C., C.M., Q.C., a non-executive director of the Company on 30 March 2007 of the exercise in London on the same day of an option granted to him under the BioChem Pharma Stock Option Plan over 2,275 shares in the capital of the Company at an exercise price of £6.20.

The Company was further notified by The Honourable James Grant on 30 March 2007 of the sale in London on the same day of 2,275 ordinary 5p shares in the capital of the Company at a price of £10.52.

The options exercised by The Honourable James Grant were granted on 6 May 1997 and were due to expire on 5 May 2007.

As a result of this transaction The Honourable James Grant has an interest, including unexercised share options, in 124,020 ordinary shares of £0.05p each in the Company. This represents 0.02% of the issued share capital of that class.

T May

Company Secretary

For further information please contact:

Investor Relations		Cléa Rosenfeld (Rest of the World)		+44 1256 894 160
		Eric Rojas (North America)		+1 484 595 8252

Notes to editors

SHIRE PLC

Registered in England 2883758 Registered Office as above

acquisitions. Shire believes that a carefully selected portfolio of products with a strategically aligned and relatively small-scale sales force will deliver strong results.

For further information on Shire, please visit the Company’s website: www.shire.com.

Registered in England 2883758 Registered Office as above

EX-99.4 6 eex9904.htm

EXHIBIT 99.04

Hampshire International Business Park Chineham Basingstoke Hampshire RG24 8EP United Kingdom Tel +44 (0)1256 894000 Fax +44 (0)1256 894708 www.shire.com

Press Release

3 April 2007

Shire plc (the “Company”)

Application has been made to the UK Listing Authority and the London Stock Exchange for the listing of 741,812 ordinary shares of 5p each to be admitted to the Official List.

These shares, ranking pari passu in all respects with the existing shares in issue, have been allotted upon the exercise of warrants originally granted, in April 2002, to the Government of Canada as part of the arrangements entered into on the acquisition of Biochem Pharma Inc.

For further information please contact:

Investor Relations		Cléa Rosenfeld (Rest of the World)		+44 1256 894 160
		Eric Rojas (North America)		+1 484 595 8252

Notes to editors

SHIRE PLC

For further information on Shire, please visit the Company’s website: www.shire.com.

Registered in England 2883758 Registered Office as above

EX-99.5 7 eex9905.htm

EXHIBIT 99.05

Hampshire International Business Park Chineham Basingstoke Hampshire RG24 8EP United Kingdom Tel +44 (0)1256 894000 Fax +44 (0)1256 894708 www.shire.com

Press Release

3 April 2007

Shire plc ("Shire")

Purchase of Shares by Employee Benefit Trust

Shire has been notified that on 2 April 2007, the Shire plc Employee Benefit Trust (the “Trust”) purchased 30,000 Ordinary Shares of Shire plc (“Shares”) at an average price of 1039.11 pence per Share. The Trust also purchased 10,000 American Depositary Receipts of Shire plc (“ADR’s”) at an average price of 62.0976 dollars per ADR.

This/these purchase(s) was/were made pursuant to the Trustee’s irrevocable, non-discretionary programme to purchase Shares and ADR’s during the period commencing 02 April 2007 and ending on 30 April 2007.

All of the employees of Shire plc and its subsidiaries, including the Executive Directors and persons exercising managerial responsibility, are potential beneficiaries of the Trust. The Executive Directors and persons exercising managerial responsibility over Shire are therefore deemed to have an interest in the Shares held by the Trust.

For further information please contact:

Investor Relations		Cléa Rosenfeld (Rest of the World)		+44 1256 894 160
		Eric Rojas (North America)		+1 484 595 8252

Notes to editors

SHIRE PLC

Registered in England 2883758 Registered Office as above

acquisitions. Shire believes that a carefully selected portfolio of products with a strategically aligned and relatively small-scale sales force will deliver strong results.

For further information on Shire, please visit the Company’s website: www.shire.com.

Registered in England 2883758 Registered Office as above

-----END PRIVACY-ENHANCED MESSAGE-----